These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

475 related items for PubMed ID: 26010355

  • 1. Prime-boost vaccination with toxoplasma lysate antigen, but not with a mixture of recombinant protein antigens, leads to reduction of brain cyst formation in BALB/c mice.
    Wagner A, Schabussova I, Ruttkowski B, Peschke R, Kur J, Kundi M, Joachim A, Wiedermann U.
    PLoS One; 2015; 10(5):e0126334. PubMed ID: 26010355
    [Abstract] [Full Text] [Related]

  • 2. Plant Hsp90 is a novel adjuvant that elicits a strong humoral and cellular immune response against B- and T-cell epitopes of a Toxoplasma gondii SAG1 peptide.
    Sánchez-López EF, Corigliano MG, Albarracín RM, Sander VA, Legarralde A, Bengoa-Luoni SA, Clemente M.
    Parasit Vectors; 2019 Mar 25; 12(1):140. PubMed ID: 30909938
    [Abstract] [Full Text] [Related]

  • 3. Protective efficacy induced by DNA prime and recombinant protein boost vaccination with Toxoplasma gondii GRA14 in mice.
    Pagheh AS, Sarvi S, Gholami S, Asgarian-Omran H, Valadan R, Hassannia H, Ahmadpour E, Fasihi-Ramandie M, Dodangeh S, Hosseni-Khah Z, Daryani A.
    Microb Pathog; 2019 Sep 25; 134():103601. PubMed ID: 31212035
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of immune responses induced by SAG1 and MIC3 vaccine cocktails against Toxoplasma gondii.
    Fang R, Feng H, Hu M, Khan MK, Wang L, Zhou Y, Zhao J.
    Vet Parasitol; 2012 Jun 08; 187(1-2):140-6. PubMed ID: 22336771
    [Abstract] [Full Text] [Related]

  • 5. Protection via a ROM4 DNA vaccine and peptide against Toxoplasma gondii in BALB/c mice.
    Han Y, Zhou A, Lu G, Zhao G, Wang L, Guo J, Song P, Zhou J, Zhou H, Cong H, He S.
    BMC Infect Dis; 2017 Jan 11; 17(1):59. PubMed ID: 28077075
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A recombinant pseudorabies virus expressing TgSAG1 protects against challenge with the virulent Toxoplasma gondii RH strain and pseudorabies in BALB/c mice.
    Liu Q, Gao S, Jiang L, Shang L, Men J, Wang Z, Zhai Y, Xia Z, Hu R, Zhang X, Zhu XQ.
    Microbes Infect; 2008 Oct 11; 10(12-13):1355-62. PubMed ID: 18761418
    [Abstract] [Full Text] [Related]

  • 8. Recombinant TgHSP70 Immunization Protects against Toxoplasma gondii Brain Cyst Formation by Enhancing Inducible Nitric Oxide Expression.
    Czarnewski P, Araújo ECB, Oliveira MC, Mineo TWP, Silva NM.
    Front Cell Infect Microbiol; 2017 Oct 11; 7():142. PubMed ID: 28487847
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Immunogenicity and protective efficacy of two recombinant pseudorabies viruses expressing Toxoplasma gondii SAG1 and MIC3 proteins.
    Nie H, Fang R, Xiong BQ, Wang LX, Hu M, Zhou YQ, Zhao JL.
    Vet Parasitol; 2011 Sep 27; 181(2-4):215-21. PubMed ID: 21632181
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Enhancement of protective immune responses induced by Toxoplasma gondii dense granule antigen 7 (GRA7) against toxoplasmosis in mice using a prime-boost vaccination strategy.
    Min J, Qu D, Li C, Song X, Zhao Q, Li XA, Yang Y, Liu Q, He S, Zhou H.
    Vaccine; 2012 Aug 17; 30(38):5631-6. PubMed ID: 22789504
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Modified protection against Toxoplasma gondii lethal infection and brain cyst formation by vaccination with SAG2 and SRS1.
    Mishima M, Xuan X, Shioda A, Omata Y, Fujisaki K, Nagasawa H, Mikami T.
    J Vet Med Sci; 2001 Apr 17; 63(4):433-8. PubMed ID: 11346179
    [Abstract] [Full Text] [Related]

  • 15. Propranolol efficacy as a novel adjuvant for immunization against Toxoplasma gondii tachyzoites.
    Minaei S, Shahabi S, Seyyedi S, Ziaali N, Mohammadzadeh Hajipirloo H.
    Exp Parasitol; 2018 Nov 17; 194():60-66. PubMed ID: 30253134
    [Abstract] [Full Text] [Related]

  • 16. Protection in mice immunized with a heterologous prime-boost regime using DNA and recombinant pseudorabies expressing TgSAG1 against Toxoplasma gondii challenge.
    Shang L, Liu Q, Liu W, Men J, Gao S, Jiang L, Wang Z, Zhai Y, Jin H, Lian H, Chen C, Xia Z, Yuan Z, Zhu XQ.
    Vaccine; 2009 May 11; 27(21):2741-5. PubMed ID: 19428887
    [Abstract] [Full Text] [Related]

  • 17. The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma Gondii is a novel vaccine candidate against toxoplasmosis in mice.
    Zheng B, Lu S, Tong Q, Kong Q, Lou D.
    Vaccine; 2013 Sep 23; 31(41):4578-84. PubMed ID: 23928460
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Immunogenic characterization of the chimeric surface antigen 1 and 2 (SAG1/2) of Toxoplasma gondii expressed in the yeast Pichia pastoris.
    Lau YL, Thiruvengadam G, Lee WW, Fong MY.
    Parasitol Res; 2011 Sep 23; 109(3):871-8. PubMed ID: 21455621
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.